Integrated Approach to Treatment of Children and Adults With Eosinophilic Esophagitis

Gastrointestinal Endoscopy Clinics of North America

Volumn 18, Issue 1, 2008, Pages 195-217

  Aceves, Seema S ^a   Furuta, Glenn T ^b   Spechler, Stuart Jon ^c  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; INTERLEUKIN 5 ANTIBODY; MONTELUKAST; PLACEBO; PREDNISONE; PROTON PUMP INHIBITOR; SUCRALOSE;

ADULTHOOD; ALLERGY TEST; CHILDHOOD; CLINICAL EXAMINATION; CLINICAL TRIAL; COMORBIDITY; CORTICOSTEROID THERAPY; DIET RESTRICTION; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ELEMENTAL DIET; ENDOSCOPIC BIOPSY; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANDIDIASIS; ESOPHAGUS DILATATION; ESOPHAGUS INJURY; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; HUMAN; LONG TERM CARE; NONHUMAN; PATCH TEST; PEDIATRICS; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; XEROSTOMIA;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; ALLERGENS; CHILD; EOSINOPHILIA; EOSINOPHILS; ESOPHAGITIS; ESOPHAGUS; FEMALE; FOOD HYPERSENSITIVITY; GASTROESOPHAGEAL REFLUX; HUMANS; INFLAMMATION; MALE; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; RISK FACTORS;

EID: 36448985200     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2007.09.003     Document Type: Review

References (87)

1. Furuta G.T., Liacouras C., Collins M.H., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterol 133 (2007) 1342-1363
2. Ruchelli E., Wenner W., Voytek T., et al. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 2 (1999) 15
3. Winter H.S., Madara J.L., Stafford R.J., et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 83 (1982) 818
4. Aceves S.S., Newbury R.O., Dohil R., et al. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol 41 (2007) 252
5. Dahms B.B. Reflux esophagitis: sequelae and differential diagnosis in infants and children including eosinophilic esophagitis. Pediatr Dev Pathol 7 (2004) 5
6. Ngo P., Furuta G.T., Antonioli D.A., et al. Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 101 (2006) 1666
7. Noel R.J., and Tipnis N.A. Eosinophilic esophagitis-a mimic of GERD. Int J Pediatr Otorhinolaryngol 70 (2006) 1147
8. Parfitt J.R., Gregor J.C., Suskin N.G., et al. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol 19 (2006) 90
9. Steiner S.J., Gupta S.K., Croffie J.M., et al. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Am J Gastroenterol 99 (2004) 801
10. Steiner S.J., Kernek K.M., and Fitzgerald J.F. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 42 (2006) 506
11. Walsh S., Antonioli D., Goldman H., et al. Allergic esophagitis in children-A clinicopathological entity. Am J Surg Pathol 23 (1999) 390
12. Blanchard C., Wang N., Stringer K.F., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116 (2006) 536
13. Kirsch R., Bokhary R., Marcon M.A., et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 44 (2007) 20
14. Spechler S.J., Genta R.M., and Souza R.F. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 102 (2007) 1301
15. Rafiee P., Theriot M.E., Nelson V.M., et al. Human esophageal microvascular endothelial cells respond to acidic pH stress by PI3K/AKT and p38 MAPK-regulated induction of Hsp70 and Hsp27. Am J Physiol Cell Physiol 291 (2006) C931
16. Cheng L., Cao W., Behar J., et al. Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle. J Pharmacol Exp Ther 319 (2006) 117
17. Hollwarth M.E., Smith M., Kvietys P.R., et al. Esophageal blood flow in the cat. Normal distribution and effects of acid perfusion. Gastroenterology 90 (1986) 622
18. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448
19. Shaheen N., and Provenzale D. The epidemiology of gastroesophageal reflux disease. Am J Med Sci 326 (2003) 264
20. Gonsalves N., Policarpio-Nicolas M., Zhang Q., et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 64 (2006) 313
21. Sant'Anna A.M., Rolland S., Fournet J.C., et al. Eosinophilic esophagitis in children: symptoms, histology and pH probe results. J Pediatr Gastroenterol Nutr 39 (2004) 373
22. Remedios M., Campbell C., Jones D.M., et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 63 (2006) 3
23. Cheng L., Harnett K.M., Cao W., et al. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. Gastroenterology 129 (2005) 1675
24. Farre R., Auli M., Lecea B., et al. Pharmacologic characterization of intrinsic mechanisms controlling tone and relaxation of porcine lower esophageal sphincter. J Pharmacol Exp Ther 316 (2006) 1238
25. Cao W., Cheng L., Behar J., et al. IL-1beta signaling in cat lower esophageal sphincter circular muscle. Am J Physiol Gastrointest Liver Physiol 291 (2006) G672
26. Cao W., Cheng L., Behar J., et al. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1131
27. Sgouros S.N., Bergele C., and Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 18 (2006) 211
28. Straumann A., Spichtin H.P., Grize L., et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125 (2003) 1660
29. Motojima S., Frigas E., Loegering D.A., et al. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 139 (1989) 801
30. Tai P.C., Hayes D.J., Clark J.B., et al. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J 204 (1982) 75
31. Young J.D., Peterson C.G., Venge P., et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321 (1986) 613
32. Furuta G.T., Nieuwenhuis E.E., Karhausen J., et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 289 (2005) G890
33. Barlow W.J., and Orlando R.C. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 128 (2005) 771
34. Ohashi Y., Motojima S., Fukuda T., et al. [Relationship between bronchial reactivity to inhaled acetylcholine, eosinophil infiltration and a widening of the intercellular space in patients with asthma]. Arerugi 39 (1990) 1541 [in Japanese]
35. Tobey N.A., Carson J.L., Alkiek R.A., et al. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 111 (1996) 1200
36. Genta R.M., Jon Spechler S., and Souza R.F. The twentieth eosinophil. Adv Anat Pathol 14 (2007) 340
37. Tobey N.A., Hosseini S.S., Argote C.M., et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 99 (2004) 13
38. Untersmayr E., and Jensen-Jarolim E. The effect of gastric digestion on food allergy. Curr Opin Allergy Clin Immunol 6 (2006) 214
39. Astwood J.D., Leach J.N., and Fuchs R.L. Stability of food allergens to digestion in vitro. Nat Biotechnol 14 (1996) 1269
40. Scholl I., Ackermann U., Ozdemir C., et al. Anti-ulcer treatment during pregnancy induces food allergy in mouse mothers and a Th2-bias in their offspring. Faseb J 21 (2007) 1264
41. Scholl I., Untersmayr E., Bakos N., et al. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB/c mice and humans. Am J Clin Nutr 81 (2005) 154
42. Untersmayr E., Bakos N., Scholl I., et al. Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. Faseb J 19 (2005) 656
43. Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113 (2004) 11
44. De Angelis P., Markowitz J.E., Torroni F., et al. Paediatric eosinophilic oesophagitis: towards early diagnosis and best treatment. Dig Liver Dis 38 (2006) 245
45. Kagalwalla A.F., Sentongo T.A., Ritz S., et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 4 (2006) 1097
46. Liacouras C.A., Spergel J.M., Ruchelli E., et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 3 (2005) 1198
47. Markowitz J.E., Spergel J.M., Ruchelli E., et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 98 (2003) 777
48. Spergel J.M., Andrews T., Brown-Whitehorn T.F., et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 95 (2005) 336
49. Spergel J.M., Beausoleil J.L., Mascarenhas M., et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 109 (2002) 363
50. Teitelbaum J., Fox V., Twarog F., et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 122 (2002) 1216
51. Spergel J.M., Brown-Whitehorn T., Beausoleil J.L., et al. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol 119 (2007) 509
52. Yamazaki K., Murray J.A., Arora A.S., et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci 51 (2006) 1934
53. Jones M., Campbell K.A., Duggan C., et al. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr 33 (2001) 602
54. Simon D., Marti H., Heer P., et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 115 (2005) 1090
55. Simon D., Straumann A., Wenk A., et al. Eosinophilic esophagitis in adults-no clinical relevance of wheat and rye sensitizations. Allergy 61 (2006) 1480
56. Fogg M.I., Ruchelli E., and Spergel J.M. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 112 (2003) 796
57. Mishra A., Hogan S.P., Brandt E.B., et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107 (2001) 83
58. Onbasi K., Sin A.Z., Doganavsargil B., et al. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 35 (2005) 1423
59. Mishra A., Hogan S.P., Brandt E.B., et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 168 (2002) 2464
60. Mishra A., and Rothenberg M.E. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 125 (2003) 1419
61. Mishra A., Schlotman J., Wang M., et al. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol 81 (2007) 916
62. Esposito S., Marinello D., Paracchini R., et al. Long-term follow-up of symptoms and peripheral eosinophil counts in seven children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 38 (2004) 452
63. Konikoff M.R., Blanchard C., Kirby C., et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol 4 (2006) 1328
64. Bullock J.Z., Villanueva J.M., Blanchard C., et al. Interplay of adaptive Th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45 (2007) 22
65. Lucendo A.J., and De Rezende L. Endoscopic dilation in eosinophilic esophagitis: a treatment strategy associated with a high risk of perforation. Endoscopy 39 (2007) 376 author reply: 377
66. Prasad G.A., and Arora A.S. Spontaneous perforation in the ringed esophagus. Dis Esophagus 18 (2005) 406
67. Aceves S.S., Newbury R.O., Dohil R., et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 119 (2007) 206
68. Attwood S.E., Lewis C.J., Bronder C.S., et al. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 52 (2003) 181
69. Spergel J.M. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr Opin Allergy Clin Immunol 7 (2007) 274
70. Gonsalves N., et al. A prospective clinical trial of allergy testing and food elimination diet in adults with eosinophilic esophagitis. Gastroenterol 132 (2007) A6
71. Liacouras C.A., Wenner W.J., Brown K., et al. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 26 (1998) 380
72. Konikoff M.R., Noel R.J., Blanchard C., et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131 (2006) 1381
73. Noel R.J., Putnam P.E., Collins M.H., et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2 (2004) 568
74. Aceves S.S., Dohil R., Newbury R.O., et al. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 116 (2005) 705
75. Arora A.S., Perrault J., and Smyrk T.C. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 78 (2003) 830
76. Faubion Jr. W.A., Perrault J., Burgart L.J., et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 27 (1998) 90
77. Aceves S.S., Bastian J.F., Newbury R.O., et al. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 102 (2007) 2271-2279
78. Lucendo A.J., Navarro M., Comas C., et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 31 (2007) 598
79. Assa'ad A.H., Putnam P.E., Collins M.H., et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 119 (2007) 731-738
80. Pentiuk S.P., Miller C.K., and Kaul A. Eosinophilic esophagitis in infants and toddlers. Dysphagia 22 (2007) 44
81. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 343 (2000) 1054
82. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354 (2006) 1985
83. Fox V.L., Nurko S., Teitelbaum J.E., et al. High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc 57 (2003) 30
84. Stein M.L., Collins M.H., Villanueva J.M., et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118 (2006) 1312
85. Spechler S.J. American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 117 (1999) 229
86. Morrow J.B., Vargo J.J., Goldblum J.R., et al. The ringed esophagus: histological features of GERD. Am J Gastroenterol 96 (2001) 984
87. Gonsalves N., and Hirano I. Safety and response of esophageal dilation in adults with eosinophilic esophagitis (EE): a single center experience of 81 patients. Gastroenterol 132 (2007) A607